BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 38531930)

  • 1. Correlation analysis of disulfidptosis-related gene signatures with clinical prognosis and immunotherapy response in sarcoma.
    Xu J; Guo K; Sheng X; Huang Y; Wang X; Dong J; Qin H; Wang C
    Sci Rep; 2024 Mar; 14(1):7158. PubMed ID: 38531930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatics-based analysis of the relationship between disulfidptosis and prognosis and treatment response in pancreatic cancer.
    Xiong Y; Kong X; Mei H; Wang J; Zhou S
    Sci Rep; 2023 Dec; 13(1):22218. PubMed ID: 38097783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disulfidptosis characterizes the tumor microenvironment and predicts immunotherapy sensitivity and prognosis in bladder cancer.
    Pan G; Xie H; Xia Y
    Heliyon; 2024 Feb; 10(3):e25573. PubMed ID: 38356551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancancer analysis reveals the role of disulfidptosis in predicting prognosis, immune infiltration and immunotherapy response in tumors.
    Huang J; Xu Z; Chen D; Zhou C; Shen Y
    Medicine (Baltimore); 2023 Dec; 102(52):e36830. PubMed ID: 38206694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosstalk of disulfidptosis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in bladder cancer based on a machine learning survival framework.
    Zhao S; Wang L; Ding W; Ye B; Cheng C; Shao J; Liu J; Zhou H
    Front Endocrinol (Lausanne); 2023; 14():1180404. PubMed ID: 37152941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disulfidptosis classification of hepatocellular carcinoma reveals correlation with clinical prognosis and immune profile.
    Wang T; Guo K; Zhang D; Wang H; Yin J; Cui H; Wu W
    Int Immunopharmacol; 2023 Jul; 120():110368. PubMed ID: 37247499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The disulfidptosis-related signature predicts prognosis and immune features in glioma patients.
    Wang X; Yang J; Yang F; Mu K
    Sci Rep; 2023 Oct; 13(1):17988. PubMed ID: 37864127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disulfidptosis-related genes of prognostic signature and immune infiltration features in hepatocellular carcinoma supported by bulk and single-cell RNA sequencing data.
    Wang Y; Yuan Z; Zhu Q; Ma J; Lu Q; Xiao Z
    J Gastrointest Oncol; 2024 Feb; 15(1):377-396. PubMed ID: 38482234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine learning- and WGCNA-mediated double analysis based on genes associated with disulfidptosis, cuproptosis and ferroptosis for the construction and validation of the prognostic model for breast cancer.
    Xu L; Wang S; Zhang D; Wu Y; Shan J; Zhu H; Wang C; Wang Q
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16511-16523. PubMed ID: 37712959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of disulfidptosis related subtypes, characterization of tumor microenvironment infiltration, and development of DRG prognostic prediction model in RCC, in which
    Xu K; Zhang Y; Yan Z; Wang Y; Li Y; Qiu Q; Du Y; Chen Z; Liu X
    Front Immunol; 2023; 14():1205250. PubMed ID: 37426643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of disulfidptosis-associated clusters on breast cancer survival rates and guiding personalized treatment.
    Chen X; Hu G; Yu Q
    Front Endocrinol (Lausanne); 2023; 14():1256132. PubMed ID: 38116315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and validation of a disulfidptosis-related genes prognostic signature in lung adenocarcinoma.
    Zhang Y; Sun J; Li M; Hou L; Wang Z; Dong H; Xu W; Jiang R; Geng Y; Guan C; Zhu Z; Wang H; Gong Q; Zhang G
    Heliyon; 2024 Jan; 10(1):e23502. PubMed ID: 38223725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of a novel molecular classification based on disulfidptosis-related genes to predict prognosis and immunotherapy efficacy in hepatocellular carcinoma.
    Yang L; Zhang W; Yan Y
    Aging (Albany NY); 2023 Jul; 15(13):6135-6151. PubMed ID: 37399661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of disulfidptosis-related subtypes, characterization of tumor microenvironment infiltration, and development of a prognosis model in breast cancer.
    Liang J; Wang X; Yang J; Sun P; Sun J; Cheng S; Liu J; Ren Z; Ren M
    Front Immunol; 2023; 14():1198826. PubMed ID: 38035071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disulfidptosis-related signature predicts prognosis and characterizes the immune microenvironment in hepatocellular carcinoma.
    Tang J; Peng X; Xiao D; Liu S; Tao Y; Shu L
    Cancer Cell Int; 2024 Jan; 24(1):19. PubMed ID: 38195525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated analysis of disulfidptosis-related immune genes signature to boost the efficacy of prognostic prediction in gastric cancer.
    Li J; Yu T; Sun J; Ma M; Zheng Z; He Y; Kang W; Ye X
    Cancer Cell Int; 2024 Mar; 24(1):112. PubMed ID: 38528532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the role of disulfidptosis-related signatures in immune microenvironment, prognosis and therapeutic strategies of cervical cancer.
    Jin T; Yin T; Xu R; Liu H; Yuan S; Xue Y; Zhang J; Wang H
    Transl Oncol; 2024 Jun; 44():101938. PubMed ID: 38492499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a disulfidptosis-related scoring system to predict clinical outcome and immunotherapy response in acute myeloid leukemia by integrated analysis of single-cell and bulk RNA-sequencing.
    Zhong F; Jiang J; Yao FY; Liu J; Shuai X; Wang XL; Huang B; Wang X
    Front Pharmacol; 2023; 14():1272701. PubMed ID: 38053840
    [No Abstract]   [Full Text] [Related]  

  • 19. Leveraging a gene signature associated with disulfidptosis identified by machine learning to forecast clinical outcomes, immunological heterogeneities, and potential therapeutic targets within lower-grade glioma.
    Zhou Y; Cao Y; Liu W; Wang L; Kuang Y; Zhou Y; Chen Q; Cheng Z; Huang H; Zhang W; Jiang X; Wang B; Ren C
    Front Immunol; 2023; 14():1294459. PubMed ID: 38162649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel application of the ferroptosis-related genes risk model associated with disulfidptosis in hepatocellular carcinoma prognosis and immune infiltration.
    Wei J; Wang J; Chen X; Zhang L; Peng M
    PeerJ; 2024; 12():e16819. PubMed ID: 38317842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.